Cargando…

Autologous Hematopoietic Stem Cell Transplantation for Treatment of Systemic Sclerosis

Systemic Sclerosis (SSc) is a complex autoimmune disease, characterized by high mortality and morbidity. The heterogeneity in terms of extent, severity, and rate of progression of skin and internal organ involvement gives rise to many difficulties in finding the optimal therapeutic interventions for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Papa, Nicoletta, Pignataro, Francesca, Zaccara, Eleonora, Maglione, Wanda, Minniti, Antonina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198074/ https://www.ncbi.nlm.nih.gov/pubmed/30386340 http://dx.doi.org/10.3389/fimmu.2018.02390

Ejemplares similares

Regional grafting of autologous adipose tissue is effective in inducing prompt healing of indolent digital ulcers in patients with systemic sclerosis: results of a monocentric randomized controlled study
por: Del Papa, Nicoletta, et al.
Publicado: (2019)

Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity
por: Minniti, Antonina, et al.
Publicado: (2020)

Cellular-Based Therapies in Systemic Sclerosis: From Hematopoietic Stem Cell Transplant to Innovative Approaches
por: Xue, Elisabetta, et al.
Publicado: (2022)

Management of Sjögren's Syndrome: Present Issues and Future Perspectives
por: Vitali, Claudio, et al.
Publicado: (2021)

High NEMO score values in nailfold videocapillaroscopy are associated with the subsequent development of ischaemic digital ulcers in patients with systemic sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2020)

Instruments for Outcome Evaluation of Specific Domains in Primary Sjögren’s Syndrome
por: Del Papa, Nicoletta, et al.
Publicado: (2021)

Impact of COVID-19 outbreak in an Italian cohort of patients with systemic sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2020)

NEMO score in nailfold videocapillaroscopy is a good tool to assess both steady state levels and overtime changes of disease activity in patients with systemic sclerosis: a comparison with the proposed composite indices for this disease status entity
por: Pignataro, Francesca, et al.
Publicado: (2019)

Gene Expression Profiles in Primary Sjögren's Syndrome With and Without Systemic Manifestations
por: Vitali, Claudio, et al.
Publicado: (2019)

The Role of Endothelial Progenitors in the Repair of Vascular Damage in Systemic Sclerosis
por: Del Papa, Nicoletta, et al.
Publicado: (2018)

Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients?
por: Del Papa, Nicoletta, et al.
Publicado: (2020)

Regenerating Immunotolerance in Multiple Sclerosis with Autologous Hematopoietic Stem Cell Transplant
por: Massey, Jennifer C., et al.
Publicado: (2018)

Immunological Adverse Events After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients
por: Strunz, Patrick-Pascal, et al.
Publicado: (2021)

The Role of Interferons in the Pathogenesis of Sjögren’s Syndrome and Future Therapeutic Perspectives
por: Del Papa, Nicoletta, et al.
Publicado: (2021)

The cumulative number of micro-haemorrhages and micro-thromboses in nailfold videocapillaroscopy is a good indicator of disease activity in systemic sclerosis: a validation study of the NEMO score
por: Andracco, Romina, et al.
Publicado: (2017)

Nailfold videocapillaroscopy micro-haemorrhage and giant capillary counting as an accurate approach for a steady state definition of disease activity in systemic sclerosis
por: Sambataro, Domenico, et al.
Publicado: (2014)

Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients—High Efficacy of Rituximab
por: Gernert, Michael, et al.
Publicado: (2022)

Quantification of Ground Glass Opacities Can Be Useful to Describe Disease Activity in Systemic Sclerosis
por: Sambataro, Domenico, et al.
Publicado: (2020)

NK Cells and Innate-Like T Cells After Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis
por: Ruder, Josefine, et al.
Publicado: (2021)

Life after Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
por: Moraes, Daniela A, et al.
Publicado: (2021)

A Future for Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
por: van Megen, Kayleigh M., et al.
Publicado: (2018)

Case Report: Effectiveness of secukinumab in systemic sclerosis with early skin progress after autologous hematopoietic stem cell transplantation and end-stage kidney disease
por: Strunz, Patrick-Pascal, et al.
Publicado: (2023)

Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis
por: Darlington, Peter J., et al.
Publicado: (2018)

Case report: A successful second autologous hematopoietic stem cell transplantation in refractory systemic sclerosis, with positive effect on skin involvement, pulmonary function and microcirculation
por: Haverkort, D.A., et al.
Publicado: (2022)

Resetting the T Cell Compartment in Autoimmune Diseases With Autologous Hematopoietic Stem Cell Transplantation: An Update
por: Lutter, Lisanne, et al.
Publicado: (2018)

Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: From Mechanistic Insights to Biomarkers
por: Malmegrim, Kelen Cristina Ribeiro, et al.
Publicado: (2018)

Immune Reconstitution Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: A Review on Behalf of the EBMT Autoimmune Diseases Working Party
por: Cencioni, Maria Teresa, et al.
Publicado: (2022)

Safety profile of autologous hematopoietic stem cell mobilization and transplantation in patients with systemic sclerosis
por: Helbig, Grzegorz, et al.
Publicado: (2017)

Autologous hematopoietic stem cell transplantation in progressive severe multiple sclerosis
por: Pandit, Awadh Kishor, et al.
Publicado: (2015)

The role of innate immune cells in systemic sclerosis in the context of autologous hematopoietic stem cell transplantation
por: Servaas, N. H., et al.
Publicado: (2020)

Autologous hematopoietic stem cell transplantation promotes connective tissue remodeling in systemic sclerosis patients
por: Zanin-Silva, Djúlio C., et al.
Publicado: (2022)

Autologous hematopoietic stem cell transplantation modifies specific aspects of systemic sclerosis-related microvasculopathy
por: Santana-Gonçalves, Maynara, et al.
Publicado: (2022)

Intensive immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of multiple sclerosis
por: Lycke, Jan, et al.
Publicado: (2020)

Autologous Hematopoietic Stem Cell Transplantation (AHSCT): An Evolving Treatment Avenue in Multiple Sclerosis
por: Mohammadi, Reihane, et al.
Publicado: (2021)

Immunological Balance Is Associated with Clinical Outcome after Autologous Hematopoietic Stem Cell Transplantation in Type 1 Diabetes
por: Malmegrim, Kelen C. R., et al.
Publicado: (2017)

Associations of Ficolins With Hematological Malignancies in Patients Receiving High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantations
por: Świerzko, Anna S., et al.
Publicado: (2020)

CD4+ T Cell Dependent B Cell Recovery and Function After Autologous Hematopoietic Stem Cell Transplantation
por: Heck, Clarissa, et al.
Publicado: (2021)

Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
por: Rozier, Pauline, et al.
Publicado: (2018)

Positron Emission Tomography to Improve Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis Eligible for Autologous Stem Cell Transplantation
por: Broens, Bo, et al.
Publicado: (2022)

Editorial: Immune Profile After Autologous Hematopoietic Stem Cell Transplantation for Autoimmune Diseases: Where Do We Stand?
por: Malmegrim, Kelen Cristina Ribeiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j65put5n1j2g9p38p5mll07l0a